{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:43:57Z","timestamp":1792025037331,"version":"4.4.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systemic disease caused by nontyphoidal <jats:italic>Salmonella<\/jats:italic> (NTS) represents a major cause of death and morbidity, especially in young children in sub-Saharan Africa. No licensed vaccine is yet available, and an increase in antimicrobial resistance makes the development of a vaccine a global health priority. We are developing a bivalent formulation of <jats:italic>Salmonella<\/jats:italic> Typhimurium and <jats:italic>Salmonella<\/jats:italic> Enteritidis generalized modules for membrane antigens (GMMA)\u2013based vaccine (iNTS-GMMA) and a trivalent formulation (iNTS-TCV) in which iNTS-GMMA is combined with the WHO-prequalified TYPHIBEV (Biological E, India) vaccine to prevent typhoid fever in addition to invasive NTS (iNTS) disease. Here, we measured the ability of antibodies induced by iNTS-GMMA and iNTS-TCV formulations in mice and rabbits to kill a broad panel of <jats:italic>Salmonella in vitro<\/jats:italic> in a complement-mediated fashion. These organisms include those causing invasive disease in Africa and Southeast Asia, global representatives causing gastroenteritis and other <jats:italic>S<\/jats:italic>. <jats:italic>enterica<\/jats:italic> serovars in addition to <jats:italic>S.<\/jats:italic> Typhimurium and <jats:italic>S.<\/jats:italic> Enteritidis. We characterized the O-antigen of the panel of isolates and demonstrated the sera functionality in both animal species against all isolates, providing evidence of the potential broad coverage of both GMMA-based formulations, which are currently undergoing testing in Phase I\/II clinical trials.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1610067","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T09:52:32Z","timestamp":1750413152000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["GMMA-based vaccine candidates against invasive nontyphoidal salmonellosis elicit bactericidal antibodies against a panel of epidemiologically relevant Salmonellae"],"prefix":"10.3389","volume":"16","author":[{"given":"Daniele","family":"De Simone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Aruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Benincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Carducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Citiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Iturriza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elli","family":"Mylona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.072","article-title":"Nontyphoidal salmonella disease: Current status of vaccine research and development","volume":"34","author":"Tennant","year":"2016","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1473-3099(21)00615-0","article-title":"Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis","volume":"22","author":"Marchello","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30418-9","article-title":"The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad041","article-title":"Salmonella combination vaccines: moving beyond typhoid","volume":"10","author":"MacLennan","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005659","article-title":"The genomic epidemiology of multi-drug resistant invasive non-typhoidal Salmonella in selected sub-Saharan African countries","volume":"6","author":"Park","year":"2021","journal-title":"BMJ Glob Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12916-020-01652-4","article-title":"Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment","volume":"18","author":"Tack","year":"2020","journal-title":"BMC Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1038\/s41467-023-41152-6","article-title":"A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa","volume":"14","author":"Van Puyvelde","year":"2023","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2016.1189330","article-title":"Immunology, epidemiology and mathematical modelling towards a better understanding of invasive non-typhoidal Salmonella disease and rational vaccination approaches","volume":"15","author":"Mastroeni","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-072938","article-title":"Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort","volume":"13","author":"Hanumunthadu","year":"2023","journal-title":"BMJ Open"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2270596","article-title":"The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development","volume":"22","author":"Skidmore","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2043103","DOI":"10.1080\/21645515.2022.2043103","article-title":"A multicenter, single-blind, randomized, phase-2\/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E\u2019s Vi-capsular polysaccharide-CRM(197) conjugate typhoid vaccine (TyphiBEV(TM)) in healthy infants, children, and adults in comparison with a licensed comparator","volume":"18","author":"Thuluva","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e35616","DOI":"10.1371\/journal.pone.0035616","article-title":"High yield production process for Shigella outer membrane particles","volume":"7","author":"Berlanda Scorza","year":"2012","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.566570","article-title":"Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants","volume":"289","author":"Rossi","year":"2014","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00023-16","article-title":"Toll-like receptor activation by generalized modules for membrane antigens from lipid A mutants of salmonella enterica serovars typhimurium and enteritidis","volume":"23","author":"Rossi","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00219-20","article-title":"Antibodies and protection in systemic salmonella infections: do we still have more questions than answers","volume":"88","author":"Mastroeni","year":"2020","journal-title":"Infect Immun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13000","article-title":"The essential role of complement in antibody-mediated resistance","volume":"156","author":"Omar Rossi","year":"2018","journal-title":"Immunology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/mps5060100","article-title":"Development and characterization of a luminescence-based high-throughput serum bactericidal assay (L-SBA) to assess bactericidal activity of human sera against nontyphoidal salmonella","volume":"5","author":"Aruta","year":"2022","journal-title":"Methods Protoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1807655115","article-title":"Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella","volume":"115","author":"Micoli","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.06.029","article-title":"Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis","volume":"83","author":"Marchello","year":"2021","journal-title":"J Infect"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/S0950268823001693","article-title":"Prevalence and distribution of non-typhoidal Salmonella enterica serogroups and serovars isolated from normally sterile sites: A global systematic review","volume":"152","author":"Hagedoorn","year":"2023","journal-title":"Epidemiol Infect"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003573","article-title":"Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from Kenya","volume":"9","author":"Onsare","year":"2015","journal-title":"PloS Negl Trop Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1900-1_14","article-title":"Methods for assessment of OMV\/GMMA quality and stability","volume":"2414","author":"Micoli","year":"2022","journal-title":"Methods Mol Biol"},{"key":"B23","volume-title":"O-antigen extraction, purification, and chemical conjugation to a carrier protein.pdf","author":"Micoli","year":""},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.089","article-title":"Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella","volume":"35","author":"De Benedetto","year":"2017","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172163","article-title":"Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout","volume":"12","author":"Necchi","year":"2017","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1347813","article-title":"O-Antigen decorations in Salmonella enterica play a key role in eliciting functional immune responses against heterologous serovars in animal models","volume":"14","author":"Gasperini","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/gr.091017.109","article-title":"Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype","volume":"19","author":"Kingsley","year":"2009","journal-title":"Genome Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"104597","DOI":"10.1016\/j.amsu.2022.104597","article-title":"Outbreak of monophasic Salmonella Typhimurium Sequence Type 34 linked to chocolate products","volume":"82","author":"Lund","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1038\/s41467-019-11844-z","article-title":"An African Salmonella Typhimurium ST313 sublineage with extensive drug-resistance and signatures of host adaptation","volume":"10","author":"Van Puyvelde","year":"2019","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000059","article-title":"Adding function to the genome of African Salmonella Typhimurium ST313 strain D23580","volume":"17","author":"Canals","year":"2019","journal-title":"PloS Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.63580-0","article-title":"Nomenclature and taxonomy of the genus Salmonella","volume":"55","author":"Tindall","year":"2005","journal-title":"Int J Syst Evol Microbiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3644","article-title":"Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings","volume":"48","author":"Feasey","year":"2016","journal-title":"Nat Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/MRA.01452-20","article-title":"Complete genome sequences of african salmonella enterica serovar enteritidis clinical isolates associated with bloodstream infection","volume":"10","author":"Perez-Sepulveda","year":"2021","journal-title":"Microbiol Resour Announc"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.63579-0","article-title":"The type species of the genus Salmonella Lignieres 1900 is Salmonella enterica (ex Kauffmann and Edwards 1952) Le Minor and Popoff 1987, with the type strain LT2T, and conservation of the epithet enterica in Salmonella enterica over all earlier epithets that may be applied to this species. Opinion 80","volume":"55","year":"2005","journal-title":"Int J Syst Evol Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1610067\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T09:52:34Z","timestamp":1750413154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1610067\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2025.1610067"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1610067","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"article-number":"1610067"}}